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 Multidrug-resistant Acinetobacter baumannii isolates, and particularly 
carbapenemase-producing isolates, are increasingly reported worldwide. The 
biochemically-based Carba NP test, extensively validated for detection of 
carbapenemase producers among Enterobacteriaceae and Pseudomonas spp., has 
been modified for the detection of carbapenemase production in Acinetobacter spp. 
A collection of 151 carbapenemase-producing and 69 non-carbapenemase producing 
Acinetobacter spp. using the Carba NP test and a modified Carba NP protocol 
(CarbAcineto NP test) set up in this study. The CarbAcineto NP test requires 
modified lysis conditions and an increased bacterial inoculum as compared to the 
original Carba NP test. The Carba NP test detects metallo-β-lactamase producers 
but failed to detect production of other carbapenemase types among Acinetobacter 
spp. By contrast, the newly-designed CarbAcineto NP test, which is rapid and 
reproducible, detects all types of carbapenemases, with a sensitivity of 94.7% and a 
specificity of 100%. This cost-effective technique offers a reliable and affordable 
technique for identification of carbapenemase production in Acinetobacter spp., 
which is a marker of multidrug resistance in those species. Its use will facilitate their 
recognition and prevent their spread. 
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Introduction 
Acinetobacter spp., and particularly the A. baumannii-calicoaceticus complex, are 
opportunistic pathogens frequently involved in nosocomial outbreaks that mostly 
occurred in intensive care units (ICU). Those infections range from septicemia to 
pneumonia and urinary tract infections (1). Due to their ability to develop resistance to 
new antibiotic rapidly, multidrug-resistant strains belonging to the A. baumannii-
calicoaceticus complex have been increasingly reported during the last decade (2). 
Consequently, carbapenems are often considered to be the antibiotic of last resort to treat 
infections caused by those strains. Therefore, resistance to carbapenems in those species 
is per se considered to define the isolate to be highly resistant. 
During the recent years, the spread of carbapenem-resistant Acinetobacter spp. 
became a worldwide issue. In Acinetobacter sp., resistance to carbapenems may result 
from (i) decreased permeability of the outer membrane due to the loss or modification of 
porins, (ii) rarely modification of penicillin-binding proteins, and (iii) in most cases 
production of a carbapenemase (2). Those carbapenemases identified in Acinetobacter sp. 
either belong to the Ambler classes A, B, or D. Some class A carbapenemases have been 
identified, being of the KPC or GES types (3, 4). Whereas KPC-producing isolates have 
been rarely described (4), dissemination of GES-11 and GES-14-producing isolates was 
recently reported in the Middle East (5). Metallo-β-lactamases (MBLs) (Ambler class B) 
of VIM-, IMP-, SIM- and NDM-types have been also reported in Acinetobacter spp. (2, 
6). Apart from SIM, all those MBLs have been also reported from Enterobacteriaceae and 
Pseudomonas spp. (7). In addition, carbapenem-hydrolyzing Ambler class D β-
lactamases (CHDLs) constitute the first source of acquired carbapenem resistance in 
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Acinetobacter spp. Those CHDLs are divided into five different subgroups, namely 
OXA-23, OXA-40, OXA-51, OXA-58, and OXA-143 (2, 8, 9). As opposed to KPC and 
MBLs, these CHDLs have been identified only among Acinetobacter spp. isolates. OXA-
51-like enzymes are intrinsic and chromosomally-encoded in the A. baumannii-
calicoaceticus complex, possessing a weak carbapenemase activity, and sharing weak 
amino acid identity with the other known class D ß-lactamases (10-12). Although the 
blaOXA-51-like genes are usually not expressed in a wild-type isolate, insertion of ISAba1 
at the 5’ end of blaOXA-51-like genes may lead to the overexpression of the corresponding 
β-lactamase gene (13). On the other hand, genes encoding OXA-23, OXA-40, OXA-58, 
and OXA-143 CHDLs have been mainly identified onto transferable genetic structures, 
such as plasmids or transposons that contribute to their dissemination among the 
Acinetobacter genus (2). 
Since most of those carbapenemases identified in Acinetobacter sp. are located on 
mobile genetic elements that may be transferred to other clinical relevant species (i.e 
other Acinetobacter species, Enterobacteriaceae, and P. aeruginosa), it is critical to 
identify those carbapenemase-producing Acinetobacter and consequently differentiate 
them from isolates that are carbapenem resistant due to non-transferable mechanisms (i.e. 
permeability defects, overexpression of efflux pumps). Rapid identification of NDM-
producing A. baumannii-calicoaceticus complex may help to limit the dissemination of 
carbapenemase genes not only in Acinetobacter genus but also in Enterobacteriaceae 
through a rapid identification of their potential reservoirs (7). 
Due to its intrinsic low permeability, detection of carbapenemase production in 
Acinetobacter genus is considered to be more difficult than in Enterobacteriaceae and 
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Pseudomonas spp. Several phenotypic techniques have been proposed to detect 
carbapenemase-producing Acinetobacter spp. (14). The modified Hodge test has been 
largerly used for this purpose. It is based on the in-vitro detection of the carbapenemase 
activity therefore inactivating the antibiotic effect. Although this test is efficient for the 
detection of IMP and VIM producers, NDM producers and CHDL producers may remain 
undetected, leading to false-negative results (15). Several techniques using the inhibition 
properties of EDTA were also proposed for the detection of MBL-producing 
Acinetobacter spp. Those techniques include the combined disk test and the Etest MBL 
strip (15, 16). However, those techniques are not highly sensitive or specific, and they 
require an additional period of growth of 24h. 
Biochemical detection of carbapenemase production using UV spectrophotometry 
has also been proposed (17). This technique efficiently detects VIM, IMP, and SIM 
producers, but NDM and CHDL producers remain difficult to detect (15). Recently, 
detection of carbapenemase production using MALDI-TOF mass spectrometry has been 
proposed for Acinetobacter spp. (18-20). It is based on the detection of the spectra of 
imipenem and of its hydrolyzed product, respectively. It shows good sensitivity and 
specificity, but requires trained microbiologists and expensive equipment. Finally, 
molecular-based techniques using specific primers are useful to identify carbapenemase 
genes. Simplex or multiplex PCR methods are available (21), as well as real-time PCR 
approaches having the advantage to provide a result in 3 hours (22). More recently, a 
DNA microarray has been developed to detect 91 target sequences associated with 
antibiotic resistance within 4 h from bacterial culture to result (23). Although those 
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molecular-based tests are highly sensitive and specific, they fail to detect unknown 
carbapenemase genes, or those that are not included in the panel of the considered test. 
One of the most promising technique for the rapid and accurate detection of any 
carbapenemase producer is the Carba NP test. This test is based on the biochemical 
detection of the hydrolysis of the β-lactam ring of imipenem (24, 25). Although the Carba 
NP test has been extensively validated worldwide for the detection of carbapenemase 
producers among Enterobacteriaceae and Pseudomonas spp. (24, 26), it has not been 
validated for the detection of carbapenemase-producing Acinetobacter spp. The 
imipenem hydrolysis rates actually obtained with those CHDLs are too low to be detected 
by the Carba NP test in its original version. The aim of this study was to further evaluate 
the Carba NP test for detection of carbapenemase producers in Acinetobacter spp. and to 
settle a modified version of the Carba NP test, the CarbAcineto NP test, for an optimal 
detection of this activity in Acinetobacter spp. 
 
MATERIALS AND METHODS 
Strain collection. A total of 220 strains were used to evaluate the performance of 
the CarbAcineto NP test. They were from various clinical origins (blood culture, urine, 
sputum) and of worldwide origin. Those strains had previously been characterized for 
their carbapenemase content at the molecular level (Tables 1 and 2). This strain collection 
included the most frequently acquired carbapenemases identified in human A. baumannii 
clinical isolates (Table 1). Those carbapenemases were OXA-23 (n = 68), OXA-24/-40-
like (n = 19), OXA-58-like (n = 26), OXA-143-like (n = 3), GES (n = 8), IMP (n = 2), 
VIM (n = 1), SIM (n = 1), and NDM (n = 14). Nine isolates co-produced two 
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carbapenemases; GES-11 + OXA-23 (n = 6) and NDM-1 + OXA-23 (n = 3). Negative 
controls (n = 69) included (i) wild-type strains (n = 51), (ii) narrow-spectrum ß-lactamase 
producers (n = 3) and (iii) extended-spectrum ß-lactamases producers (n = 12) (Table 2). 
Three strains overexpressing their chromosome-encoded blaOXA-51-like carbapenemase 
genes were also tested (Table 2). 
Susceptibility testing. Susceptibility testing was performed by determining MIC 
values using the Etest® (bioMérieux; La Balmes-les-Grottes, France) on Mueller-Hinton 
agar plates at 37°C and results were recorded according to US guidelines (CLSI), as 
updated in 2013. The breakpoints for imipenem ad meropenem were susceptible (S)  4 
and resistant (R)  16 μg/ml. 
Carba NP test. The Carba NP test is based on the colorimetric and pH-based 
detection of hydrolysis of the ȕ-lactam ring of imipenem. The updated protocol of the 
Carba NP test was performed on bacterial isolates grown on Trypticase Soy (TS) agar 
(bioMérieux) as previously described (25). 
CarbAcineto NP test. The CarbAcineto NP test was adapted from the updated 
version of the Carba NP test used for the detection of carbapenemase-producing 
Enterobacteriaceae and Pseudomonas spp. (25), in order to be used for Acinetobacter spp. 
Compared to this updated version, the lysis buffer was replaced by a 5M NaCl solution 
avoiding any buffer effect, and the bacterial inoculum was doubled from third to half of a 
calibrated loop (10 l) to a full calibrated loop in order to increase the enzyme quantity. 
Briefly, a full calibrated loop (10 l) of the tested strain was recovered from TS agar 
plates and resuspended in two 1.5 ml eppendorf tubes (A and B) containing 100 l NaCl 
5M. In tube A (internal control), 100 l of the revealing solution containing a pH 
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indicator (phenol red) was added. In tube B (test tube), 100 l of an extemporaneously 
prepared revelation solution supplemented with imipenem at 6 mg/ml was added. Tubes 
A and B were incubated at 37°C for a maximum of 2 h. Optical reading of the color 
change of each tube was performed. The carbapenemase activity was detected by a color 
change of phenol red solution (red to yellow/orange) in tube B resulting from the 
hydrolysis of imipenem into a carboxylic derivative leading to a decrease of the pH value. 
Results of the CarbAcineto NP test were interpreted as follows: (i) tube A red and tube B 
remaining red, non carbapenemase-producing isolate, (ii) tube A red and tube B turning 
yellow/orange, carbapenemase-producing strain and (iii) tube A and tube B both turning 
yellow/orange, non-interpretable result. The phenol red revealing solution was prepared 
as previously described (24). The NaCl 5M solution was prepared from a dilution of 
NaCl powder (Sigma-Aldrich, Saint Quentin Fallavier, France) in distilled water. 
 
RESULTS 
Using the updated protocol of the Carba NP test set up for detection of the 
carbapenemase activity in Enterobacteriaceae and Pseudomonas spp., positive results 
were obtained only for MBL-producing Acinetobacter spp. (Table 1). The Carba NP test 
failed to detect Acinetobacter spp. isolates producing carbapenemase of the GES- and/or 
OXA-types (Table 1). This test did not detect any carbapenemase activity among strains 
being resistant to carbapenems due to the overexpression of their intrinsic OXA-51-like 
enzyme (Table 2). Accordingly, the specificity and sensitivity of the Carba NP test for the 
detection of Acinetobacter spp. isolates producing an acquired carbapenemase were 
found to be 100% and 11.9% only, respectively. 
8
ht
tp
://
do
c.
re
ro
.c
h
On the other hand, the CarbAcineto NP test allowed to detect all isolates 
producing an acquired carbapenemase, with the exception of some GES-type producers 
(Table 1, Figure 1B). Isolates being carbapenem-resistant due to overexpression of their 
chromosome-encoded OXA-51-like β-lactamase (Table 2, Figure 1C) or to non-
carbapenemase-mediated mechanisms such as combined mechanisms of resistance 
(outer-membrane permeability defect +/- associated with overproduction of 
cephalosporinase and/or ESBLs) also remained negative with this test (Table 2, Figure 
1A). In most cases, positive results gave frank color change from red to yellow (Figure 
B). For MBL producers, a positive result was always obtained in less than 15 minutes. 
For ca. 13% (9/68) of the OXA-23 producers and ca. 23% (6/22) of the OXA-58-like 
producers, the color in the test tube (tube B) turned from red to orange but only after 2 
hours of incubation (Figure 1B). However, this color change was easy to detect when 
looking at the upper part of the tubes after vortexing (Figure 1B). Among the 211 tested 
strains of Acinetobacter spp., only two gave non-interpretable results (Table 2, Figure 
1D). The specificity and sensitivity of the CarbAcineto NP test were therefore estimated 
to be 100% and 94.7%, respectively. 
DISCUSSION 
The Carba NP test, initially set up for detection of carbapenemase-producing 
Enterobacteriaceae and Pseudomonas spp., efficiently detects MBL-producing 
Acinetobacter spp. However, it fails to detect OXA-type carbapenemases which are the 
most frequently identified carbapenemases among Acinetobacter spp. Since those 
CHDLs found in Acinetobacter spp. (OXA-23, OXA-24/-40-like, OXA-58-like, OXA-
143-like) possess a weaker carbapenemase activity as compared to those usually 
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measured in Enterobacteriaceae (mostly KPC, MBLs, and OXA-48) and Pseudomonas 
spp. (mostly MBLs), we made the hypothesis that the buffer used in the Carba NP test 
may buffer at a too high level and may counteract the detection of any weak 
carbapenemase activity. 
Specificity and sensitivity of the CarbAcineto NP test were found to be 100% and 
94.7%, respectively. The CarbAcineto NP test efficiently detected the OXA-type 
carbapenemase producers leading to a significant improvement of the sensitivity (94.7% 
for the CarbAcineto NP test vs 11.9% for the Carba NP test). The better detection of 
CHDLs is due to two independent factors. First, the bacterial inoculum used in the 
CarbAcineto NP test was doubled compared to the Carba NP test, leading to an increased 
amount of enzyme released in the revealing solution. Second, the lysis buffer used for the 
Carba NP test (B-PER II, Bacterial Protein Extraction Reagent, Pierce, Thermo 
Scientific, Villebon-sur-Yvette, France) has been replaced by an hyperosmotic solution of 
NaCl 5M. Use of this latter buffer provides two main advantages. It does not buffer 
enough to interfer negatively against slight pH changes, and its hyperosmotic properties 
lead to an efficient lysis of the bacteria. Water has also been tested to substitute the B-
PER II lysis buffer, but the color changes were less clear and the test failed to detect 
nineteen carbapenemase producers (nine OXA-23 and six OXA-58-like) giving ‘orange’ 
results (data not shown). This lack of detection might be explained by the weak lysis of 
the bacteria in water compared to the hyperosmotic solution of NaCl, resulting in lower 
enzyme release. Recently, a derivative version of the Carba NP test was developed. This 
test used water instead of B-PER buffer and bromothymol blue instead of red phenol as 
pH indicator. (27) The authors claimed that the use of water instead of B-PER buffer led 
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to the detection of all carbapenemase-producing Acinetobacter spp. However, in their 
study, only fourteen OXA-23 and six OXA-58-like producers were tested, which is not 
sufficient to assess the reliability of that test, considering that only 13.2% of the OXA-23 
producers and 23.1% of the OXA-58-like producers could be detected when using water 
instead of NaCl. As previously observed using the Carba NP test with P. aeruginosa 
strains, the GES-type carbapenemase producers were not detected using the CarbAcineto 
NP test (26). The GES-type carbapenemases are point mutant analogues of the ESBL 
GES-1 and possess an extended but very weak carbapenemase activity that could explain 
this lack of detection. This lack of detection of GES-type carbapenemases in P. 
aeruginosa may be also due to a weaker release or production of GES-type 
carbapenemases in P. aeruginosa (26), since a GES-5-producing Enterobacter cloacae 
isolate was identified with the Carba NP test (24). 
Although the number of tested strains was low (3 isolates), the CarbAcineto NP 
test gave negative results when testing carbapenem-resistant Acinetobacter spp. 
overexpressing their chromosome-encoded OXA-51-like β-lactamase (Table 2). In fact, 
lack of detection of OXA-51-like overproducers may be interesting when considering the 
usefulness of the CarbAcineto NP test. Indeed, those chromosomally-encoded resistance 
mechanisms are not supposed to be transferable to other organisms, by contrast to 
plasmid-encoded mechanisms, which therefore constitutes a much less important clinical 
issue. Thus, clearly distinguishing acquired from non-acquired carbapenemase producers 
provides an added-value to the test. 
In conclusion, the CarbAcineto NP test offers a rapid and cost-effective solution 
for detecting acquired carbapenemase producers among the Acinetobacter species. It 
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might contribute to prevent the spread of those multidrug-resistant strains, but also of 
several carbapenemase genes, considering for example that blaNDM-1-like genes that 
initially spread among Acinetobacter spp. then targeted also Enterobacteriaceae and 
Pseudomonas spp. (7). Use of the CarbAcineto NP test will be interesting in particularly 
for ICU patients for whom multidrug-resistant isolates belonging to the A. baumannii-
calicoaceticus complex are a common source of severe infections. It particularly makes 
sense testing for cartbapenemase production considering that acquisition of a 
carbapenemase in A. baumannii is a marker of multidrug resistance. 
Finally, by using both the Carba NP and CarbAcineto NP tests, any microbiology 
laboratory worldwide may have the opportunity to efficiently identify one of the most 
important clinical resistance trait of modern microbiology, i.e. carbapenem resistance-
mediated mechanisms leading to multidrug- or pandrug resistance in clinically-significant 
Gram negatives. 
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Figure legend. 
Figure 1. Representative results obtained using the CarbAcineto NP test on 
Acinetobacter spp. isolates. A. Representative results obtained using the CarbAcineto NP 
test on wild-type (WT), narrow-spectrum β-lactamase-producing (OXA-21, RTG-4) and 
extended-spectrum β-lactamase-producing Acinetobacter spp. (PER-1, VEB-1, SHV-5). 
B. Representative results obtained using the CarbAcineto NP test on acquired 
carbapenemase producing Acinetobacter spp. isolates. Carbapenemase of Ambler class A 
(GES-types), Ambler class B (IMP-type, NDM-type) and Ambler class D (OXA-23, 
OXA-24/-40, OXA-58 and OXA-143) are represented. C. Representative result obtained 
using the CarbAcineto test on a carbapenem-resistant Acinetobacter spp. overexpressing 
its chromosome-encoded OXA-51 β-lactamase. D. Representative result of a non 
interpretable result using the CarbAcineto NP on a wild-type Acinetobacter spp. isolate. 
 
 
18
ht
tp
://
do
c.
re
ro
.c
h
Table 1. Results of the Carba NP and CarbAcineto NP tests when performed on Acinetobacter spp. producing 
an acquired carbapenemase. 
Carbapenemase Species n MIC (Pg/ml) Carba NP test
CarbAcineto
NP test IMP MER
Ambler class A carbapenemases 
GES-type 
GES-11 A. baumannii 3 2 4 - -
GES-14 A. baumannii 5 24 - 32 16 - 32 - -
Ambler class B carbapenemases 
NDM-type 
NDM-1 A. baumannii 13 >32 >32 + +
NDM-2 A. baumannii 1 >32 >32 + +
IMP-type 
IMP-1 A. baumannii 1 4 6 + +
IMP-4 A. baumannii 1 24 16 + +
VIM-type 
VIM-4 A. genomospecies 16 1 >32 >32 + +
SIM-type 
SIM-1 A. baumannii 1 >32 >32 + +
Ambler class D carbapenemases 
OXA-23 group 
OXA-23 A. baumannii  68 24 - >32 8 - >32 - +
OXA-40 group 
OXA-24/OXA-40 A. baumannii 8 >32 >32 - +
OXA-25 A. baumannii 1 >32 >32 - +
OXA-26 A. baumannii 1 >32 >32 - +
OXA-72 A. baumannii 9 >32 >32 - +
OXA-58 group 
OXA-58 A. baumannii 24 16 - >32 8 - >32 - +
OXA-58 A. haemolyticus  1 >32 8 - +
OXA-97 A. baumannii 1 >32 >32 - +
OXA-143 group 
OXA-143 A. baumannii 2 >32 >32 - +
OXA-293 A. baumannii 1 >32 >32 - +
Multiple carbapenemases 
GES-11 + OXA-23 A. baumannii 6  32 >32 - +
NDM-1 + OXA-23 A. baumannii 3 >32 >32 + +
IMP, imipenem ; MER, meropenem 
A. baumannii means A. baumannii-calcoaceticus complex 
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Table 2. Results of the Carba NP and CarbAcineto NP tests when testing Acinetobacter spp. strains that do not 
possess acquired carbapenemases. 
 
Acquired β-lactamase Species n MIC (μg/ml) Carba NP test 
CarbAcineto 
NP test IMP MER 
None 
 None A. baumannii 36 0.19 - 2 0.12 - 3 - - 
 None A. junii 3 0.05 - 0.09 0.05 - 0.09 - - 
 None A. lwolffi 4 0.09 - 0.19 0.09 - 0.19 - - 
 None A. ursingii 2 0.06 - 0.09 0.06 - 0.09 - - 
 None A. johnsonii 4 0.06 - 0.09 0.06 - 0.09 - - 
 None A. baumannii  1   0.5 0.75 NI - 
 None A. johnsonii 1     0.09 0.09 NI - 
Narrow-spectrum β-lactamase 
 SCO-1 A. baumannii  1     0.38 0.5 - - 
 RTG-4 A. baumannii  1     0.38 0.38 - - 
 OXA-21 A. baumannii  1     0.75 0.5 - - 
Extended-spectrum β-lactamase 
 SHV-5 A. baumannii  1 6 4 - - 
 PER-1 A. baumannii  1   1.5 1.5 - - 
 VEB-1 A. baumannii  9 0.38 - 1 0.5 - 1.5 - - 
 GES-12 A. baumannii  1 32 32 - - 
Overexpressed chromosome-encoded OXA-51-like β-lactamase 
 ISAba1 + OXA-51 A. baumannii  2 2 - 3 3 - - 
 ISAba1 + OXA-66 A. baumannii  1 4 6 - - 
 
IMP, imipenem ; MER, meropenem 
NI, not interpretable 
A. baumannii means A. baumannii-calcoaceticus complex 
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WT OXA-21 PER-1 VEB-1
ISAba1 + 
OXA-51
RTG-4
GES-11 GES-14 IMP-1 
NDM-1
OXA-58 OXA-143OXA-24/-40OXA-23
Ambler class A Ambler class B Ambler class D 
NDM-1
A
C
B
D WT
SHV-5 
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